-
1
-
-
0014760451
-
Partial purification and properties of urokinase inhibitor from human placenta
-
Kawano T, Morimoto K, Uemura Y. Partial purification and properties of urokinase inhibitor from human placenta. J Biochem 1970 67 3 333-342
-
(1970)
J Biochem
, vol.67
, Issue.3
, pp. 333-342
-
-
Kawano, T.1
Morimoto, K.2
Uemura, Y.3
-
2
-
-
0022003765
-
Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator
-
Astedt B, Lecander I, Brodin T, Lundblad A, Löw K. Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator. Thromb Haemost 1985 53 1 122-125 (Pubitemid 15135249)
-
(1985)
Thrombosis and Haemostasis
, vol.53
, Issue.1
, pp. 122-125
-
-
Astedt, B.1
Lecander, I.2
Brodin, T.3
-
3
-
-
0022360062
-
Different inhibition of one and two chain tissue plasminogen activator by a placental inhibitor studied with two tripeptide-p-nitroanilide substrates
-
Astedt B, Bladh B, Christensen U, Lecander I. Different inhibition of one and two chain tissue plasminogen activator by a placental inhibitor studied with two tripeptide-p-nitroanilide substrates. Scand J Clin Lab Invest 1985 45 5 429-435 (Pubitemid 16248455)
-
(1985)
Scandinavian Journal of Clinical and Laboratory Investigation
, vol.45
, Issue.5
, pp. 429-435
-
-
Astedt, B.1
Bladh, B.2
Christensen, U.3
Lecander, I.4
-
4
-
-
0023711754
-
Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2
-
Thorsen S, Philips M, Selmer J, Lecander I, Astedt B. Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2. Eur J Biochem 1988 175 1 33-39
-
(1988)
Eur J Biochem
, vol.175
, Issue.1
, pp. 33-39
-
-
Thorsen, S.1
Philips, M.2
Selmer, J.3
Lecander, I.4
Astedt, B.5
-
6
-
-
0028787122
-
Biological and clinical aspects of plasminogen activator inhibitor type 2
-
Kruithof E K., Baker M S., Bunn C L. Biological and clinical aspects of plasminogen activator inhibitor type 2. Blood 1995 86 11 4007-4024
-
(1995)
Blood
, vol.86
, Issue.11
, pp. 4007-4024
-
-
Kruithof, E.K.1
Baker, M.S.2
Bunn, C.L.3
-
7
-
-
0021225478
-
Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma
-
Kruithof E K., Tran-Thang C, Ransijn A, Bachmann F. Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. Blood 1984 64 4 907-913 (Pubitemid 14003614)
-
(1984)
Blood
, vol.64
, Issue.4
, pp. 907-913
-
-
Kruithof, E.K.O.1
Tran-Thang, C.2
Ransijn, A.3
Bachmann, F.4
-
8
-
-
0035823595
-
The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature
-
Silverman G A., Bird P I., Carrell R W. et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem 2001 276 36 33293-33296
-
(2001)
J Biol Chem
, vol.276
, Issue.36
, pp. 33293-33296
-
-
Silverman, G.A.1
Bird, P.I.2
Carrell, R.W.3
-
9
-
-
33747862007
-
An overview of the serpin superfamily
-
Law R H., Zhang Q, McGowan S et al. An overview of the serpin superfamily. Genome Biol 2006 7 5 216
-
(2006)
Genome Biol
, vol.7
, Issue.5
, pp. 216
-
-
Law, R.H.1
Zhang, Q.2
McGowan, S.3
-
10
-
-
0022979217
-
Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937
-
Kruithof E K., Vassalli J D., Schleuning W D., Mattaliano R J., Bachmann F. Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937. J Biol Chem 1986 261 24 11207-11213 (Pubitemid 17216724)
-
(1986)
Journal of Biological Chemistry
, vol.261
, Issue.24
, pp. 11207-11213
-
-
Kruithof, E.K.O.1
Vassalli, J.-D.2
Schleuning, W.-D.3
-
11
-
-
0023148141
-
Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells
-
DOI 10.1083/jcb.104.3.705
-
Genton C, Kruithof E K., Schleuning W D. Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells. J Cell Biol 1987 104 3 705-712 (Pubitemid 17024726)
-
(1987)
Journal of Cell Biology
, vol.104
, Issue.3
, pp. 705-712
-
-
Genton, C.1
Kruithof, E.K.O.2
Schleuning, W.-D.3
-
12
-
-
0032101523
-
The serine proteinase inhibitor (serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon α/β priming
-
DOI 10.1084/jem.187.11.1799
-
Antalis T M., La Linn M, Donnan K et al. The serine proteinase inhibitor (serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon alpha/beta priming. J Exp Med 1998 187 11 1799-1811 (Pubitemid 28262444)
-
(1998)
Journal of Experimental Medicine
, vol.187
, Issue.11
, pp. 1799-1811
-
-
Antalis, T.M.1
Linn, M.L.2
Donnan, K.3
Mateo, L.4
Gardner, J.5
Dickinson, J.L.6
Buttigieg, K.7
Suhrbier, A.8
-
13
-
-
0028874970
-
Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function
-
Dickinson J L., Bates E J., Ferrante A, Antalis T M. Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function. J Biol Chem 1995 270 46 27894-27904
-
(1995)
J Biol Chem
, vol.270
, Issue.46
, pp. 27894-27904
-
-
Dickinson, J.L.1
Bates, E.J.2
Ferrante, A.3
Antalis, T.M.4
-
14
-
-
0031817915
-
The C-D interhelical domain of the serpin plasminogen activator inhibitor-type 2 is required for protection from TNF-α induced apoptosis
-
Dickinson J L., Norris B J., Jensen P H., Antalis T M. The C-D interhelical domain of the serpin plasminogen activator inhibitor-type 2 is required for protection from TNF-alpha induced apoptosis. Cell Death Differ 1998 5 2 163-171 (Pubitemid 28356553)
-
(1998)
Cell Death and Differentiation
, vol.5
, Issue.2
, pp. 163-171
-
-
Dickinson, J.L.1
Norris, B.J.2
Jensen, P.H.3
Antalis, T.M.4
-
15
-
-
29144502242
-
Evidence for serpinB2-independent protection from TNF-α-induced apoptosis
-
DOI 10.1016/j.yexcr.2005.11.003, PII S0014482705005240
-
Fish R J., Kruithof E K. Evidence for serpinB2-independent protection from TNF-alpha-induced apoptosis. Exp Cell Res 2006 312 3 350-361 (Pubitemid 41814843)
-
(2006)
Experimental Cell Research
, vol.312
, Issue.3
, pp. 350-361
-
-
Fish, R.J.1
Kruithof, E.K.O.2
-
17
-
-
26244444789
-
The undecided serpin: The ins and outs of plasminogen activator inhibitor type 2
-
DOI 10.1111/j.1742-4658.2005.04879.x
-
Medcalf R L., Stasinopoulos S J. The undecided serpin. The ins and outs of plasminogen activator inhibitor type 2. FEBS J 2005 272 19 4858-4867 (Pubitemid 41415110)
-
(2005)
FEBS Journal
, vol.272
, Issue.19
, pp. 4858-4867
-
-
Medcalf, R.L.1
Stasinopoulos, S.J.2
-
18
-
-
45849151069
-
Revisiting the biological roles of PAI2 (SERPINB2) in cancer
-
DOI 10.1038/nrc2400, PII NRC2400
-
Croucher D R., Saunders D N., Lobov S, Ranson M. Revisiting the biological roles of PAI2 (SERPINB2) in cancer. Nat Rev Cancer 2008 8 7 535-545 (Pubitemid 351881848)
-
(2008)
Nature Reviews Cancer
, vol.8
, Issue.7
, pp. 535-545
-
-
Croucher, D.R.1
Saunders, D.N.2
Lobov, S.3
Ranson, M.4
-
19
-
-
0024551332
-
Structure of the gene for human plasminogen activator inhibitor-2. The nearest mammalian homologue of chicken ovalbumin
-
Ye R D., Ahern S M., Le Beau M M., Lebo R V., Sadler J E. Structure of the gene for human plasminogen activator inhibitor-2. The nearest mammalian homologue of chicken ovalbumin. J Biol Chem 1989 264 10 5495-5502 (Pubitemid 19098003)
-
(1989)
Journal of Biological Chemistry
, vol.264
, Issue.10
, pp. 5495-5502
-
-
Ye, R.D.1
Ahern, S.M.2
Le Beau, M.M.3
Lebo, R.V.4
Sadler, J.E.5
-
20
-
-
0027393310
-
The ovalbumin family of serpin proteins
-
DOI 10.1016/0014-5793(93)81143-N
-
Remold-O'Donnell E. The ovalbumin family of serpin proteins. FEBS Lett 1993 315 2 105-108 (Pubitemid 23015865)
-
(1993)
FEBS Letters
, vol.315
, Issue.2
, pp. 105-108
-
-
Remold-O'Donnell, E.1
-
21
-
-
0033572439
-
Human ovalbumin serpin evolution: Phylogenic analysis, gene organization, and identification of new PI8-related genes suggest that two interchromosomal and several intrachromosomal duplications generated the gene clusters at 18q21-q23 and 6p25
-
DOI 10.1006/geno.1999.6021
-
Scott F L., Eyre H J., Lioumi M et al. Human ovalbumin serpin evolution: phylogenic analysis, gene organization, and identification of new PI8-related genes suggest that two interchromosomal and several intrachromosomal duplications generated the gene clusters at 18q21-q23 and 6p25. Genomics 1999 62 3 490-499 (Pubitemid 30075180)
-
(1999)
Genomics
, vol.62
, Issue.3
, pp. 490-499
-
-
Scott, F.L.1
Eyre, H.J.2
Lioumi, M.3
Ragoussis, J.4
Irving, J.A.5
Sutherland, G.A.6
Bird, P.I.7
-
22
-
-
9344241444
-
Structural bases of the redox-dependent conformational switch in the serpin PAI-2
-
DOI 10.1016/j.jmb.2004.10.010, PII S0022283604012914
-
Lobov S, Wilczynska M, Bergström F, Johansson L B., Ny T. Structural bases of the redox-dependent conformational switch in the serpin PAI-2. J Mol Biol 2004 344 5 1359-1368 (Pubitemid 39555485)
-
(2004)
Journal of Molecular Biology
, vol.344
, Issue.5
, pp. 1359-1368
-
-
Lobov, S.1
Wilczynska, M.2
Bergstrom, F.3
Johansson, L.B.-A.4
Ny, T.5
-
23
-
-
0023124557
-
Plasminogen activator-specific inhibitors produced by human monocytes/macrophages
-
DOI 10.1084/jem.165.2.320
-
Wohlwend A, Belin D, Vassalli J D. Plasminogen activator-specific inhibitors produced by human monocytes/macrophages. J Exp Med 1987 165 2 320-339 (Pubitemid 17019818)
-
(1987)
Journal of Experimental Medicine
, vol.165
, Issue.2
, pp. 320-339
-
-
Wohlwend, A.1
Belin, D.2
Vassalli, J.-D.3
-
24
-
-
0027144057
-
Macrophage colony-stimulating factor and granulocyte-macrophage colony- stimulating factor stimulate the synthesis of plasminogen-activator inhibitors by human monocytes
-
Hamilton J A., Whitty G A., Stanton H et al. Macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor stimulate the synthesis of plasminogen-activator inhibitors by human monocytes. Blood 1993 82 12 3616-3621 (Pubitemid 24006042)
-
(1993)
Blood
, vol.82
, Issue.12
, pp. 3616-3621
-
-
Hamilton, J.A.1
Whitty, G.A.2
Stanton, H.3
Wojta, J.4
Gallichio, M.5
McGrath, K.6
Ianches, G.7
-
25
-
-
0030791210
-
Regulation, location and activity of plasminogen activator inhibitor 2 (PAI-2) in peripheral blood monocytes, macrophages and foam cells
-
Ritchie H, Jamieson A, Booth N A. Regulation, location and activity of plasminogen activator inhibitor 2 (PAI-2) in peripheral blood monocytes, macrophages and foam cells. Thromb Haemost 1997 77 6 1168-1173 (Pubitemid 27311989)
-
(1997)
Thrombosis and Haemostasis
, vol.77
, Issue.6
, pp. 1168-1173
-
-
Ritchie, H.1
Jamieson, A.2
Booth, N.A.3
-
26
-
-
4744345349
-
Plasminogen activator inhibitor-2 (PAI-2) in eosinophilic leukocytes
-
DOI 10.1189/jlb.0304182
-
Swartz J M., Byström J, Dyer K D., Nitto T, Wynn T A., Rosenberg H F. Plasminogen activator inhibitor-2 (PAI-2) in eosinophilic leukocytes. J Leukoc Biol 2004 76 4 812-819 (Pubitemid 39313717)
-
(2004)
Journal of Leukocyte Biology
, vol.76
, Issue.4
, pp. 812-819
-
-
Swartz, J.M.1
Bystrom, J.2
Dyer, K.D.3
Nitto, T.4
Wynn, T.A.5
Rosenberg, H.F.6
-
27
-
-
0030977016
-
S100A11, S100A10, annexin I, desmosomal proteins, small proline-rich proteins, plasminogen activator inhibitor-2, and involucrin are components of the cornified envelope of cultured human epidermal keratinocytes
-
DOI 10.1074/jbc.272.18.12035
-
Robinson N A., Lapic S, Welter J F., Eckert R L. S100A11, S100A10, annexin I, desmosomal proteins, small proline-rich proteins, plasminogen activator inhibitor-2, and involucrin are components of the cornified envelope of cultured human epidermal keratinocytes. J Biol Chem 1997 272 18 12035-12046 (Pubitemid 27202781)
-
(1997)
Journal of Biological Chemistry
, vol.272
, Issue.18
, pp. 12035-12046
-
-
Robinson, N.A.1
Lapic, S.2
Welter, J.F.3
Eckert, R.L.4
-
28
-
-
0027760936
-
Microglia express the type 2 plasminogen activator inhibitor in the brain of control subjects and patients with Alzheimer's disease
-
DOI 10.1016/0304-3940(93)90899-V
-
Akiyama H, Ikeda K, Kondo H, Kato M, McGeer P L. Microglia express the type 2 plasminogen activator inhibitor in the brain of control subjects and patients with Alzheimer's disease. Neurosci Lett 1993 164 12 233-235 (Pubitemid 24040723)
-
(1993)
Neuroscience Letters
, vol.164
, Issue.1-2
, pp. 233-235
-
-
Akiyama, H.1
Ikeda, K.2
Kondo, H.3
Kato, M.4
McGeer, P.L.5
-
29
-
-
0023149587
-
Fibrinolysis in pregnancy: A study of plasminogen activator inhibitors
-
Kruithof E K., Tran-Thang C, Gudinchet A et al. Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood 1987 69 2 460-466 (Pubitemid 17022014)
-
(1987)
Blood
, vol.69
, Issue.2
, pp. 460-466
-
-
Kruithof, E.K.O.1
Chien Tran-Thang2
Gudinchet, A.3
-
30
-
-
0031969760
-
The distribution of the secreted and intracellular forms of plasminogen activator inhibitor 2 (PAI-2) in human peripheral blood monocytes is modulated by serum
-
Ritchie H, Booth N A. The distribution of the secreted and intracellular forms of plasminogen activator inhibitor 2 (PAI-2) in human peripheral blood monocytes is modulated by serum. Thromb Haemost 1998 79 4 813-817 (Pubitemid 28163860)
-
(1998)
Thrombosis and Haemostasis
, vol.79
, Issue.4
, pp. 813-817
-
-
Ritchie, H.1
Booth, N.A.2
-
31
-
-
0036882395
-
Serpin structure, mechanism, and function
-
Gettins P GW. Serpin structure, mechanism, and function. Chem Rev 2002 102 12 4751-4804
-
(2002)
Chem Rev
, vol.102
, Issue.12
, pp. 4751-4804
-
-
Gettins, P.G.1
-
32
-
-
33746503823
-
Shape-shifting serpinsadvantages of a mobile mechanism
-
Huntington J A. Shape-shifting serpinsadvantages of a mobile mechanism. Trends Biochem Sci 2006 31 8 427-435
-
(2006)
Trends Biochem Sci
, vol.31
, Issue.8
, pp. 427-435
-
-
Huntington, J.A.1
-
33
-
-
0028176436
-
Differential inhibition of soluble and cell surface receptor-bound single-chain urokinase by plasminogen activator inhibitor type 2. A potential regulatory mechanism
-
Schwartz B S. Differential inhibition of soluble and cell surface receptor-bound single-chain urokinase by plasminogen activator inhibitor type 2. A potential regulatory mechanism. J Biol Chem 1994 269 11 8319-8323
-
(1994)
J Biol Chem
, vol.269
, Issue.11
, pp. 8319-8323
-
-
Schwartz, B.S.1
-
34
-
-
0024520425
-
Vascular origin determines plasminogen activator expression in human endothelial cells. Renal endothelial cells produce large amounts of single chain urokinase type plasminogen activator
-
Wojta J, Hoover R L., Daniel T O. Vascular origin determines plasminogen activator expression in human endothelial cells. Renal endothelial cells produce large amounts of single chain urokinase type plasminogen activator. J Biol Chem 1989 264 5 2846-2852 (Pubitemid 19057779)
-
(1989)
Journal of Biological Chemistry
, vol.264
, Issue.5
, pp. 2846-2852
-
-
Wojta, J.1
Hoover, R.L.2
Daniel, T.O.3
-
35
-
-
0023268616
-
The resistance of fibrin-stimulated tissue plasminogen activator to inactivation by a class pai-2 inhibitor (minactivin)
-
DOI 10.1016/0049-3848(87)90068-5
-
Leung K C., Byatt J A., Stephens R W. The resistance of fibrin-stimulated tissue plasminogen activator to inactivation by a class PAI-2 inhibitor (minactivin). Thromb Res 1987 46 6 755-766 (Pubitemid 17104490)
-
(1987)
Thrombosis Research
, vol.46
, Issue.6
, pp. 755-766
-
-
Leung, K.-C.1
Byatt, J.A.2
Stephens, R.W.3
-
37
-
-
0023192040
-
Poly-D-lysine dependent inactivation of tissue plasminogen activator by a class pai-2 inhibitor (minactivin)
-
DOI 10.1016/0049-3848(87)90069-7
-
Leung K C., Byatt J A., Stephens R W. Poly-D-lysine dependent inactivation of tissue plasminogen activator by a class PAI-2 inhibitor (minactivin). Thromb Res 1987 46 6 767-777 (Pubitemid 17104491)
-
(1987)
Thrombosis Research
, vol.46
, Issue.6
, pp. 767-777
-
-
Leung, K.-C.1
Byatt, J.A.2
Stephens, R.W.3
-
38
-
-
48949088564
-
Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: Potential receptor interactions
-
Lobov S, Croucher D R., Saunders D N., Ranson M. Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions. Thromb Haemost 2008 100 2 319-329
-
(2008)
Thromb Haemost
, vol.100
, Issue.2
, pp. 319-329
-
-
Lobov, S.1
Croucher, D.R.2
Saunders, D.N.3
Ranson, M.4
-
39
-
-
78649732417
-
Differential endocytosis of tissue plasminogen activator by serpins PAI-1 and PAI-2 on human peripheral blood monocytes
-
Lee J A., Croucher D R., Ranson M. Differential endocytosis of tissue plasminogen activator by serpins PAI-1 and PAI-2 on human peripheral blood monocytes. Thromb Haemost 2010 104 6 1133-1142
-
(2010)
Thromb Haemost
, vol.104
, Issue.6
, pp. 1133-1142
-
-
Lee, J.A.1
Croucher, D.R.2
Ranson, M.3
-
40
-
-
2942551117
-
Kinetic analysis of plasminogen activator inhibitor type-2: Urokinase complex formation and subsequent internalisation by carcinoma cell lines
-
DOI 10.1016/j.yexcr.2004.03.030, PII S0014482704001697
-
Al-Ejeh F, Croucher D, Ranson M. Kinetic analysis of plasminogen activator inhibitor type-2: urokinase complex formation and subsequent internalisation by carcinoma cell lines. Exp Cell Res 2004 297 1 259-271 (Pubitemid 38759578)
-
(2004)
Experimental Cell Research
, vol.297
, Issue.1
, pp. 259-271
-
-
Al-Ejeh, F.1
Croucher, D.2
Ranson, M.3
-
41
-
-
0023555148
-
Specific plasminogen activator inhibitor of placental type PAI 2 occurring in amniotic fluid and cord blood
-
Lecander I, Astedt B. Specific plasminogen activator inhibitor of placental type PAI 2 occurring in amniotic fluid and cord blood. J Lab Clin Med 1987 110 5 602-605 (Pubitemid 18033251)
-
(1987)
Journal of Laboratory and Clinical Medicine
, vol.110
, Issue.5
, pp. 602-605
-
-
Lecander, I.1
Astedt, B.2
-
42
-
-
0031728717
-
Significance of the plasminogen activator inhibitor of placental type (PAI-2) in pregnancy
-
Astedt B, Lindoff C, Lecander I. Significance of the plasminogen activator inhibitor of placental type (PAI-2) in pregnancy. Semin Thromb Hemost 1998 24 5 431-435 (Pubitemid 28525432)
-
(1998)
Seminars in Thrombosis and Hemostasis
, vol.24
, Issue.5
, pp. 431-435
-
-
Astedt, B.1
Lindoff, C.2
Lecander, I.3
-
43
-
-
0023857726
-
A plasminogen activator inhibitor (PAI-2) circulates in two molecular forms during pregnancy
-
Booth N A., Reith A, Bennett B. A plasminogen activator inhibitor (PAI-2) circulates in two molecular forms during pregnancy. Thromb Haemost 1988 59 1 77-79 (Pubitemid 18053654)
-
(1988)
Thrombosis and Haemostasis
, vol.59
, Issue.1
, pp. 77-79
-
-
Booth, N.A.1
Reith, A.2
Bennett, B.3
-
44
-
-
0036005961
-
The plasminogen activating system in periodontal health and disease
-
DOI 10.1515/BC.2002.008
-
Kinnby B. The plasminogen activating system in periodontal health and disease. Biol Chem 2002 383 1 85-92 (Pubitemid 34224030)
-
(2002)
Biological Chemistry
, vol.383
, Issue.1
, pp. 85-92
-
-
Kinnby, B.1
-
45
-
-
33645070241
-
Plasminogen activators and their inhibitors in human saliva and salivary gland tissue
-
DOI 10.1111/j.1600-0722.2006.00264.x
-
Virtanen O J., Sirén V, Multanen J et al. Plasminogen activators and their inhibitors in human saliva and salivary gland tissue. Eur J Oral Sci 2006 114 1 22-26 (Pubitemid 43427116)
-
(2006)
European Journal of Oral Sciences
, vol.114
, Issue.1
, pp. 22-26
-
-
Virtanen, O.J.1
Siren, V.2
Multanen, J.3
Farkkila, M.4
Leivo, I.5
Vaheri, A.6
Koskiniemi, M.7
-
46
-
-
0028897996
-
Human intraperitoneal fibrinolytic response to elective surgery
-
Scott-Coombes D, Whawell S, Vipond M N., Thompson J. Human intraperitoneal fibrinolytic response to elective surgery. Br J Surg 1995 82 3 414-417
-
(1995)
Br J Surg
, vol.82
, Issue.3
, pp. 414-417
-
-
Scott-Coombes, D.1
Whawell, S.2
Vipond, M.N.3
Thompson, J.4
-
47
-
-
0242713029
-
Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions
-
DOI 10.1042/CS20030115
-
Alemán C, Alegre J, Monasterio J et al. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions. Clin Sci (Lond) 2003 105 5 601-607 (Pubitemid 37421655)
-
(2003)
Clinical Science
, vol.105
, Issue.5
, pp. 601-607
-
-
Aleman, C.1
Alegre, J.2
Monasterio, J.3
Segura, R.M.4
Armadans, L.5
Angles, A.6
Varela, E.7
Ruiz, E.8
Fernandez De Sevilla, T.9
-
48
-
-
43949129415
-
Plasminogen activator inhibitor in human tears after laser refractive surgery
-
DOI 10.1016/j.jcrs.2008.02.024, PII S0886335008002940
-
Csutak A, Silver D M., Tozsér J et al. Plasminogen activator inhibitor in human tears after laser refractive surgery. J Cataract Refract Surg 2008 34 6 897-901 (Pubitemid 351699261)
-
(2008)
Journal of Cataract and Refractive Surgery
, vol.34
, Issue.6
, pp. 897-901
-
-
Csutak, A.1
Silver, D.M.2
Tozser, J.3
Steiber, Z.4
Bagossi, P.5
Hassan, Z.6
Berta, A.7
-
49
-
-
0025762750
-
Plasminogen activator inhibitor-2 in patients with monocytic leukemia
-
Scherrer A, Kruithof E K., Grob J P. Plasminogen activator inhibitor-2 in patients with monocytic leukemia. Leukemia 1991 5 6 479-486
-
(1991)
Leukemia
, vol.5
, Issue.6
, pp. 479-486
-
-
Scherrer, A.1
Kruithof, E.K.2
Grob, J.P.3
-
50
-
-
0034042450
-
Plasminogen activator inhibitor 2 and urokinase-type plasminogen activator in plasma and leucocytes in patients with severe sepsis
-
DOI 10.1046/j.1365-2141.2000.02057.x
-
Robbie L A., Dummer S, Booth N A., Adey G D., Bennett B. Plasminogen activator inhibitor 2 and urokinase-type plasminogen activator in plasma and leucocytes in patients with severe sepsis. Br J Haematol 2000 109 2 342-348 (Pubitemid 30350715)
-
(2000)
British Journal of Haematology
, vol.109
, Issue.2
, pp. 342-348
-
-
Robbie, L.A.1
Dummer, S.2
Booth, N.A.3
Adey, G.D.4
Bennett, B.5
-
51
-
-
0025150598
-
Occurrence of the specific plasminogen activator inhibitor of placental type, PAI-2 in ascitic fluid and tumour vessel blood from patients with ovarian carcinoma
-
DOI 10.1016/0268-9499(90)90018-F
-
Lecander I, Martinsson G, Casslén B et al. Occurrence of the specific plasminogen activator inhibitor of placental type, PAI-2 in ascitic fluid and tumour vessel blood from patients with ovarian carcinoma. Fibrinolysis 1990 4 4 221-224 (Pubitemid 20320106)
-
(1990)
Fibrinolysis
, vol.4
, Issue.4
, pp. 221-224
-
-
Lecander, I.1
Martinsson, G.2
Casslen, B.3
Andreasen, P.A.4
Astedt, B.5
-
52
-
-
0036306114
-
Identification of plasminogen activator inhibitor-2 as a gastrin-regulated gene: Role of Rho GTPase and menin
-
DOI 10.1053/gast.2002.34162
-
Varro A, Hemers E, Archer D et al. Identification of plasminogen activator inhibitor-2 as a gastrin-regulated gene: role of Rho GTPase and menin. Gastroenterology 2002 123 1 271-280 (Pubitemid 34747547)
-
(2002)
Gastroenterology
, vol.123
, Issue.1
, pp. 271-280
-
-
Varro, A.1
Hemers, E.2
Archer, D.3
Pagliocca, A.4
Haigh, C.5
Ahmed, S.6
Dimaline, R.7
Dockray, G.J.8
-
53
-
-
33748210026
-
Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy
-
DOI 10.1016/j.ejogrb.2006.02.004, PII S0301211506001035
-
Coolman M, de Groot C J., Steegers E A. et al. Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy. Eur J Obstet Gynecol Reprod Biol 2006 128 1-2 22-28 (Pubitemid 44311352)
-
(2006)
European Journal of Obstetrics Gynecology and Reproductive Biology
, vol.128
, Issue.1-2
, pp. 22-28
-
-
Coolman, M.1
De Groot, C.J.M.2
Steegers, E.A.P.3
Geurts-Moespot, A.4
Thomas, C.M.G.5
Steegers-Theunissen, R.P.M.6
Sweep, F.C.G.J.7
-
54
-
-
65849304182
-
Pregnancy outcome and fibrinolytic, endothelial and coagulation markers in women undergoing uterine artery Doppler screening at 23 weeks
-
Hunt B J., Missfelder-Lobos H, Parra-Cordero M et al. Pregnancy outcome and fibrinolytic, endothelial and coagulation markers in women undergoing uterine artery Doppler screening at 23 weeks. J Thromb Haemost 2009 7 6 955-961
-
(2009)
J Thromb Haemost
, vol.7
, Issue.6
, pp. 955-961
-
-
Hunt, B.J.1
Missfelder-Lobos, H.2
Parra-Cordero, M.3
-
55
-
-
7044249206
-
Haemostatic changes in pregnancy
-
DOI 10.1016/j.thromres.2004.08.004, PII S0049384804004475
-
Brenner B. Haemostatic changes in pregnancy. Thromb Res 2004 114 56 409-414 (Pubitemid 39422573)
-
(2004)
Thrombosis Research
, vol.114
, Issue.5-6 SPEC. ISS.
, pp. 409-414
-
-
Brenner, B.1
-
56
-
-
0027520899
-
Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, pre-eclampsia and hydatidiform mole
-
Reith A, Booth N A., Moore N R., Cruickshank D J., Bennett B. Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, pre-eclampsia and hydatidiform mole. Br J Obstet Gynaecol 1993 100 4 370-374 (Pubitemid 23121160)
-
(1993)
British Journal of Obstetrics and Gynaecology
, vol.100
, Issue.4
, pp. 370-374
-
-
Reith, A.1
Booth, N.A.2
Moore, N.R.3
Cruickshank, D.J.4
Bennett, B.5
-
57
-
-
0025893836
-
Identity between the placental protein PP10 and the specific plasminogen activator inhibitor of placental type PAI-2
-
Kiso U, Henschen A, Bohn H et al. Identity between the placental protein PP10 and the specific plasminogen activator inhibitor of placental type PAI-2. Biochim Biophys Acta 1991 1074 1 74-78
-
(1991)
Biochim Biophys Acta
, vol.1074
, Issue.1
, pp. 74-78
-
-
Kiso, U.1
Henschen, A.2
Bohn, H.3
-
58
-
-
0029794424
-
Fibrinolysis during normal pregnancy and severe preeclampsia relationships between plasma levels of plasminogen activators and inhibitors
-
Nakashima A, Kobayashi T, Terao T. Fibrinolysis during normal pregnancy and severe preeclampsia relationships between plasma levels of plasminogen activators and inhibitors. Gynecol Obstet Invest 1996 42 2 95-101 (Pubitemid 26285225)
-
(1996)
Gynecologic and Obstetric Investigation
, vol.42
, Issue.2
, pp. 95-101
-
-
Nakashima, A.1
Kobayashi, T.2
Terao, T.3
-
59
-
-
0029360521
-
Molecular characterization of plasminogen activators in human gingival crevicular fluid
-
Brown J M., Watanabe K, Cohen R L., Chambers D A. Molecular characterization of plasminogen activators in human gingival crevicular fluid. Arch Oral Biol 1995 40 9 839-845
-
(1995)
Arch Oral Biol
, vol.40
, Issue.9
, pp. 839-845
-
-
Brown, J.M.1
Watanabe, K.2
Cohen, R.L.3
Chambers, D.A.4
-
60
-
-
0034146658
-
Detection of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 2(PAI-2) in gingival crevicular fluid from healthy, gingivitis and periodontitis patients
-
Yin X, Bunn C L., Bartold P M. Detection of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 2(PAI-2) in gingival crevicular fluid from healthy, gingivitis and periodontitis patients. J Clin Periodontol 2000 27 3 149-156
-
(2000)
J Clin Periodontol
, vol.27
, Issue.3
, pp. 149-156
-
-
Yin, X.1
Bunn, C.L.2
Bartold, P.M.3
-
61
-
-
0032079373
-
Immunological detection of conformational neoepitopes associated with the serpin activity of plasminogen activator inhibitor type-2
-
DOI 10.1074/jbc.273.18.10965
-
Saunders D N., Buttigieg K M., Gould A, McPhun V, Baker M S. Immunological detection of conformational neoepitopes associated with the serpin activity of plasminogen activator inhibitor type-2. J Biol Chem 1998 273 18 10965-10971 (Pubitemid 28204936)
-
(1998)
Journal of Biological Chemistry
, vol.273
, Issue.18
, pp. 10965-10971
-
-
Saunders, D.N.1
Buttigieg, K.M.L.2
Gould, A.3
McPhun, V.4
Baker, M.S.5
-
62
-
-
0035215417
-
The localization of the relaxed form of plasminogen activator inhibitor type 2 in human gingival tissues
-
DOI 10.1007/s00418-001-0341-7
-
Lindberg P, Baker M S., Kinnby B. The localization of the relaxed form of plasminogen activator inhibitor type 2 in human gingival tissues. Histochem Cell Biol 2001 116 5 447-452 (Pubitemid 33141276)
-
(2001)
Histochemistry and Cell Biology
, vol.116
, Issue.5
, pp. 447-452
-
-
Lindberg, P.1
Baker, M.S.2
Kinnby, B.3
-
63
-
-
0025139477
-
Plasminogen activator inhibitor 2 (PAI-2) is not inactivated by exposure to oxidants which can be released from activated neutrophils
-
DOI 10.1016/0006-291X(90)90909-7
-
Baker M S., Green S P., Goss N, Katrantzis M, Doe W F. Plasminogen activator inhibitor 2 (PAI-2) is not inactivated by exposure to oxidants which can be released from activated neutrophils. Biochem Biophys Res Commun 1990 166 2 993-1000 (Pubitemid 20049944)
-
(1990)
Biochemical and Biophysical Research Communications
, vol.166
, Issue.2
, pp. 993-1000
-
-
Baker, M.S.1
Green, S.P.2
Goss, N.3
Katrantzis, M.4
Doe, W.F.5
-
64
-
-
0344549142
-
Dissemination risk index based on plasminogen activator system components in primary breast cancer
-
Bouchet C, Hacène K, Martin P M. et al. Dissemination risk index based on plasminogen activator system components in primary breast cancer. J Clin Oncol 1999 17 10 3048-3057 (Pubitemid 29470632)
-
(1999)
Journal of Clinical Oncology
, vol.17
, Issue.10
, pp. 3048-3057
-
-
Bouchet, C.1
Hacene, K.2
Martin, P.-M.3
Becette, V.4
Tubiana-Hulin, M.5
Lasry, S.6
Oglobine, J.7
Spyratos, F.8
-
65
-
-
0033968403
-
The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients
-
Foekens J A., Peters H A., Look M P. et al. The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients. Cancer Res 2000 60 3 636-643 (Pubitemid 30094561)
-
(2000)
Cancer Research
, vol.60
, Issue.3
, pp. 636-643
-
-
Foekens, J.A.1
Peters, H.A.2
Look, M.P.3
Portengen, H.4
Schmitt, M.5
Kramer, M.D.6
Brunner, N.7
Janicke, F.8
Meijer-van Gelder, M.E.9
Henzen-Logmans, S.C.10
Van Putten, W.L.J.11
Klijn, J.G.M.12
-
66
-
-
0345425766
-
Determination of the complex between urokinase and its type-I inhibitor in plasma from healthy donors and breast cancer patients
-
Pedersen A N., Brünner N, Høyer-Hansen G et al. Determination of the complex between urokinase and its type-1 inhibitor in plasma from healthy donors and breast cancer patients. Clin Chem 1999 45 8 Pt 1 1206-1213 (Pubitemid 29424259)
-
(1999)
Clinical Chemistry
, vol.45
, Issue.8
, pp. 1206-1213
-
-
Pedersen, A.N.1
Brunner, N.2
Hoyer-Hansen, G.3
Hamer, P.4
Jarosz, D.5
Larsen, B.6
Nielsen, H.J.7
Stephens, R.W.8
-
67
-
-
0035168874
-
Prognostic importance of the uPA/PAI-1 complex in breast cancer
-
Sten-Linder M, Seddighzadeh M, Engel G et al. Prognostic importance of the uPa/PAI-1 complex in breast cancer. Anticancer Res 2001 21 4B 2861-2865 (Pubitemid 33051142)
-
(2001)
Anticancer Research
, vol.21
, Issue.4
, pp. 2861-2865
-
-
Sten-Linder, M.1
Seddighzadeh, M.2
Engel, G.3
Rutqvist, L.E.4
Linder, S.5
Skoog, L.6
Wiman, B.7
-
68
-
-
70149106202
-
Nuclear calcium signaling controls expression of a large gene pool: Identification of a gene program for acquired neuroprotection induced by synaptic activity
-
Zhang S J., Zou M, Lu L et al. Nuclear calcium signaling controls expression of a large gene pool: identification of a gene program for acquired neuroprotection induced by synaptic activity. PLoS Genet 2009 5 8 e1000604
-
(2009)
PLoS Genet
, vol.5
, Issue.8
-
-
Zhang, S.J.1
Zou, M.2
Lu, L.3
-
69
-
-
1342292268
-
Gene microarray analysis reveals interleukin-5-dependent transcriptional targets in mouse bone marrow
-
DOI 10.1182/blood-2003-08-2778
-
Byström J, Wynn T A., Domachowske J B., Rosenberg H F. Gene microarray analysis reveals interleukin-5-dependent transcriptional targets in mouse bone marrow. Blood 2004 103 3 868-877 (Pubitemid 38129544)
-
(2004)
Blood
, vol.103
, Issue.3
, pp. 868-877
-
-
Bystrom, J.1
Wynn, T.A.2
Domachowske, J.B.3
Rosenberg, H.F.4
-
70
-
-
24944554790
-
Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis - CREB and NF-κB as key regulators
-
DOI 10.1016/j.immuni.2005.08.010, PII S1074761305002700
-
Park J M., Greten F R., Wong A et al. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosisCREB and NF-kappaB as key regulators. Immunity 2005 23 3 319-329 (Pubitemid 41319727)
-
(2005)
Immunity
, vol.23
, Issue.3
, pp. 319-329
-
-
Park, J.M.1
Greten, F.R.2
Wong, A.3
Westrick, R.J.4
Arthur, J.S.C.5
Otsu, K.6
Hoffmann, A.7
Montminy, M.8
Karin, M.9
-
71
-
-
34548225362
-
NF-κB Is a Negative Regulator of IL-1β Secretion as Revealed by Genetic and Pharmacological Inhibition of IKKβ
-
DOI 10.1016/j.cell.2007.07.009, PII S0092867407008963
-
Greten F R., Arkan M C., Bollrath J et al. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 2007 130 5 918-931 (Pubitemid 47332565)
-
(2007)
Cell
, vol.130
, Issue.5
, pp. 918-931
-
-
Greten, F.R.1
Arkan, M.C.2
Bollrath, J.3
Hsu, L.-C.4
Goode, J.5
Miething, C.6
Goktuna, S.I.7
Neuenhahn, M.8
Fierer, J.9
Paxian, S.10
Van Rooijen, N.11
Xu, Y.12
O'Cain, T.13
Jaffee, B.B.14
Busch, D.H.15
Duyster, J.16
Schmid, R.M.17
Eckmann, L.18
Karin, M.19
-
72
-
-
71949098229
-
Hypersensitivity of aryl hydrocarbon receptor-deficient mice to lipopolysaccharide-induced septic shock
-
Sekine H, Mimura J, Oshima M et al. Hypersensitivity of aryl hydrocarbon receptor-deficient mice to lipopolysaccharide-induced septic shock. Mol Cell Biol 2009 29 24 6391-6400
-
(2009)
Mol Cell Biol
, vol.29
, Issue.24
, pp. 6391-6400
-
-
Sekine, H.1
Mimura, J.2
Oshima, M.3
-
73
-
-
0033067526
-
Caspase I-related protease inhibition retards the execution of okadaic acid- and camptothecin-induced apoptosis and PAI-2 cleavage, but not commitment to cell death in HL-60 cells
-
Jensen P H., Fladmark K E., Gjertsen B T., Vintermyr O K. Caspase I-related protease inhibition retards the execution of okadaic acid- and camptothecin-induced apoptosis and PAI-2 cleavage, but not commitment to cell death in HL-60 cells. Br J Cancer 1999 79 11-12 1685-1691 (Pubitemid 29132290)
-
(1999)
British Journal of Cancer
, vol.79
, Issue.11-12
, pp. 1685-1691
-
-
Jensen, P.H.1
Fladmark, K.E.2
Gjertsen, B.T.3
Vintermyr, O.K.4
-
74
-
-
77951904395
-
A physiological function of inflammation-associated SerpinB2 is regulation of adaptive immunity
-
Schroder W A., Le T T., Major L et al. A physiological function of inflammation-associated SerpinB2 is regulation of adaptive immunity. J Immunol 2010 184 5 2663-2670
-
(2010)
J Immunol
, vol.184
, Issue.5
, pp. 2663-2670
-
-
Schroder, W.A.1
Le, T.T.2
Major, L.3
-
76
-
-
0024671148
-
Effect of dengue virus on procoagulant and fibrinolytic activities of monocytes
-
Suppl 4
-
Krishnamurti C, Alving B. Effect of dengue virus on procoagulant and fibrinolytic activities of monocytes. Rev Infect Dis 1989 11 Suppl 4 S843-S846
-
(1989)
Rev Infect Dis
, vol.11
-
-
Krishnamurti, C.1
Alving, B.2
-
77
-
-
33748464019
-
NF-κB translocation prevents host cell death after low-dose challenge by Legionella pneumophila
-
DOI 10.1084/jem.20060766
-
Losick V P., Isberg R R. NF-kappaB translocation prevents host cell death after low-dose challenge by Legionella pneumophila. J Exp Med 2006 203 9 2177-2189 (Pubitemid 44352238)
-
(2006)
Journal of Experimental Medicine
, vol.203
, Issue.9
, pp. 2177-2189
-
-
Losick, V.P.1
Isberg, R.R.2
-
78
-
-
33745763276
-
Reciprocal upregulation of urokinase plasminogen activator and its inhibitor, PAI-2, by Borrelia burgdorferi affects bacterial penetration and host-inflammatory response
-
Haile W B., Coleman J L., Benach J L. Reciprocal upregulation of urokinase plasminogen activator and its inhibitor, PAI-2, by Borrelia burgdorferi affects bacterial penetration and host-inflammatory response. Cell Microbiol 2006 8 8 1349-1360
-
(2006)
Cell Microbiol
, vol.8
, Issue.8
, pp. 1349-1360
-
-
Haile, W.B.1
Coleman, J.L.2
Benach, J.L.3
-
79
-
-
0029127095
-
Plasminogen activator inhibitor type 2 prevents programmed cell death of human macrophages infected with Mycobacterium avium, serovar 4
-
Gan H, Newman G W., Remold H G. Plasminogen activator inhibitor type 2 prevents programmed cell death of human macrophages infected with Mycobacterium avium, serovar 4. J Immunol 1995 155 3 1304-1315
-
(1995)
J Immunol
, vol.155
, Issue.3
, pp. 1304-1315
-
-
Gan, H.1
Newman, G.W.2
Remold, H.G.3
-
80
-
-
58149485457
-
Interaction analyses of human monocytes co-cultured with different forms of Aspergillus fumigatus
-
Loeffler J, Haddad Z, Bonin M et al. Interaction analyses of human monocytes co-cultured with different forms of Aspergillus fumigatus. J Med Microbiol 2009 58 Pt 1 49-58
-
(2009)
J Med Microbiol
, vol.58
, Issue.PART 1
, pp. 49-58
-
-
Loeffler, J.1
Haddad, Z.2
Bonin, M.3
-
81
-
-
0026032014
-
Yeast artificial chromosome cloning of a two-megabase-size contig within chromosomal band 18q21 establishes physical linkage between BCL2 and plasminogen activator inhibitor type-2
-
Silverman G A., Jockel J I., Domer P H., Mohr R M., Taillon-Miller P, Korsmeyer S J. Yeast artificial chromosome cloning of a two-megabase-size contig within chromosomal band 18q21 establishes physical linkage between BCL2 and plasminogen activator inhibitor type-2. Genomics 1991 9 2 219-228
-
(1991)
Genomics
, vol.9
, Issue.2
, pp. 219-228
-
-
Silverman, G.A.1
Jockel, J.I.2
Domer, P.H.3
Mohr, R.M.4
Taillon-Miller, P.5
Korsmeyer, S.J.6
-
82
-
-
0028100197
-
Cleaved intracellular plasminogen activator inhibitor 2 in human myeloleukaemia cells is a marker of apoptosis
-
Jensen P H., Cressey L I., Gjertsen B T. et al. Cleaved intracellular plasminogen activator inhibitor 2 in human myeloleukaemia cells is a marker of apoptosis. Br J Cancer 1994 70 5 834-840 (Pubitemid 24331073)
-
(1994)
British Journal of Cancer
, vol.70
, Issue.5
, pp. 834-840
-
-
Jensen, P.H.1
Cressey, L.I.2
Gjertsen, B.T.3
Madsen, P.4
Mellgren, G.5
Hokland, P.6
Gliemann, J.7
Doskeland, S.O.8
Lanotte, M.9
Vintermyr, O.K.10
-
83
-
-
0035110958
-
Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice
-
Zhou H M., Bolon I, Nichols A, Wohlwend A, Vassalli J D. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice. Cancer Res 2001 61 3 970-976 (Pubitemid 32174413)
-
(2001)
Cancer Research
, vol.61
, Issue.3
, pp. 970-976
-
-
Zhou, H.-M.1
Bolon, I.2
Nichols, A.3
Wohlwend, A.4
Vassalli, J.-D.5
-
84
-
-
0042071201
-
Identification of interaction between PAI-2 and IRF-3
-
Zhang Y Q., Li P, Hou M et al. Identification of interaction between PAI-2 and IRF-3. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 2003 35 7 661-665 (Pubitemid 36980884)
-
(2003)
Acta Biochimica et Biophysica Sinica
, vol.35
, Issue.7
, pp. 661-665
-
-
Zhang, Y.-Q.1
Li, P.2
Hou, M.3
Wang, X.4
Fan, J.5
Tan, L.6
Zhu, Y.-S.7
-
85
-
-
1942503351
-
Interaction of plasminogen activator inhibitor-2 and proteasome subunit, beta type 1
-
Fan J, Zhang Y Q., Li P et al. Interaction of plasminogen activator inhibitor-2 and proteasome subunit, beta type 1. Acta Biochim Biophys Sin (Shanghai) 2004 36 1 42-46 (Pubitemid 38507346)
-
(2004)
Acta Biochimica et Biophysica Sinica
, vol.36
, Issue.1
, pp. 42-46
-
-
Fan, J.1
Zhang, Y.-Q.2
Li, P.3
Hou, M.4
Tan, L.5
Wang, X.6
Zhu, Y.-S.7
-
86
-
-
0029861092
-
The exon 3 encoded sequence of the intracellular serine proteinase inhibitor plasminogen activator inhibitor 2 is a protein binding domain
-
DOI 10.1074/jbc.271.43.26892
-
Jensen P H., Jensen T G., Laug W E., Hager H, Gliemann J, Pepinsky B. The exon 3 encoded sequence of the intracellular serine proteinase inhibitor plasminogen activator inhibitor 2 is a protein binding domain. J Biol Chem 1996 271 43 26892-26899 (Pubitemid 26359102)
-
(1996)
Journal of Biological Chemistry
, vol.271
, Issue.43
, pp. 26892-26899
-
-
Jensen, P.H.1
Jensen, T.G.2
Laug, W.E.3
Hager, H.4
Gliemann, J.5
Pepinsky, B.6
-
87
-
-
0028246924
-
A unique interhelical insertion in plasminogen activator inhibitor-2 contains three glutamines, Gln83, Gln84, Gln86, essential for transglutaminase-mediated cross-linking
-
Jensen P H., Schüler E, Woodrow G et al. A unique interhelical insertion in plasminogen activator inhibitor-2 contains three glutamines, Gln83, Gln84, Gln86, essential for transglutaminase-mediated cross-linking. J Biol Chem 1994 269 21 15394-15398
-
(1994)
J Biol Chem
, vol.269
, Issue.21
, pp. 15394-15398
-
-
Jensen, P.H.1
Schüler, E.2
Woodrow, G.3
-
88
-
-
0032892173
-
Monocyte plasminogen activator inhibitor 2 (PAI-2) inhibits u-PA-mediated fibrin clot lysis and is cross-linked to fibrin
-
Ritchie H, Robbie L A., Kinghorn S, Exley R, Booth N A. Monocyte plasminogen activator inhibitor 2 (PAI-2) inhibits u-PA-mediated fibrin clot lysis and is cross-linked to fibrin. Thromb Haemost 1999 81 1 96-103 (Pubitemid 29041657)
-
(1999)
Thrombosis and Haemostasis
, vol.81
, Issue.1
, pp. 96-103
-
-
Ritchie, H.1
Robbie, L.A.2
Kinghorn, S.3
Exley, R.4
Booth, N.A.5
-
89
-
-
0029875393
-
Intracellular polymerization of the serpin plasminogen activator inhibitor type 2
-
DOI 10.1074/jbc.271.17.10048
-
Mikus P, Ny T. Intracellular polymerization of the serpin plasminogen activator inhibitor type 2. J Biol Chem 1996 271 17 10048-10053 (Pubitemid 26131562)
-
(1996)
Journal of Biological Chemistry
, vol.271
, Issue.17
, pp. 10048-10053
-
-
Mikus, P.1
Ny, T.2
-
90
-
-
0037446935
-
A redox-sensitive loop regulates plasminogen activator inhibitor type 2 (PAI-2) polymerization
-
DOI 10.1093/emboj/cdg178
-
Wilczynska M, Lobov S, Ohlsson P I., Ny T. A redox-sensitive loop regulates plasminogen activator inhibitor type 2 (PAI-2) polymerization. EMBO J 2003 22 8 1753-1761 (Pubitemid 36460132)
-
(2003)
EMBO Journal
, vol.22
, Issue.8
, pp. 1753-1761
-
-
Wilczynska, M.1
Lobov, S.2
Ohlsson, P.-I.3
Ny, T.4
-
91
-
-
0042691816
-
Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif
-
DOI 10.1128/MCB.23.18.6520-6532.2003
-
Darnell G A., Antalis T M., Johnstone R W. et al. Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif. Mol Cell Biol 2003 23 18 6520-6532 (Pubitemid 37075763)
-
(2003)
Molecular and Cellular Biology
, vol.23
, Issue.18
, pp. 6520-6532
-
-
Darnell, G.A.1
Antalis, T.M.2
Johnstone, R.W.3
Stringer, B.W.4
Ogbourne, S.M.5
Harrich, D.6
Suhrbier, A.7
-
92
-
-
15244361972
-
Silencing of integrated human papillomavirus type 18 oncogene transcription in cells expressing SerpinB2
-
DOI 10.1128/JVI.79.7.4246-4256.2005
-
Darnell G A., Antalis T M., Rose B R., Suhrbier A. Silencing of integrated human papillomavirus type 18 oncogene transcription in cells expressing SerpinB2. J Virol 2005 79 7 4246-4256 (Pubitemid 40388363)
-
(2005)
Journal of Virology
, vol.79
, Issue.7
, pp. 4246-4256
-
-
Darnell, G.A.1
Antalis, T.M.2
Rose, B.R.3
Suhrbier, A.4
-
93
-
-
72949087974
-
Up-regulation of plasminogen activator inhibitor-2 is associated with high-risk HPV and grade of cervical lesion at baseline but does not predict outcomes of high-risk HPV infections or incident CIN
-
Syrjänen S, Naud P, Sarian L et al. Up-regulation of plasminogen activator inhibitor-2 is associated with high-risk HPV and grade of cervical lesion at baseline but does not predict outcomes of high-risk HPV infections or incident CIN. Am J Clin Pathol 2009 132 6 883-892
-
(2009)
Am J Clin Pathol
, vol.132
, Issue.6
, pp. 883-892
-
-
Syrjänen, S.1
Naud, P.2
Sarian, L.3
-
94
-
-
33845966418
-
SerpinB2 is an inducible host factor involved in enhancing HIV-1 transcription and replication
-
DOI 10.1074/jbc.M604220200
-
Darnell G A., Schroder W A., Gardner J et al. SerpinB2 is an inducible host factor involved in enhancing HIV-1 transcription and replication. J Biol Chem 2006 281 42 31348-31358 (Pubitemid 46041399)
-
(2006)
Journal of Biological Chemistry
, vol.281
, Issue.42
, pp. 31348-31358
-
-
Darnell, G.A.1
Schroder, W.A.2
Gardner, J.3
Harrich, D.4
Yu, H.5
Medcalf, R.L.6
Warrilow, D.7
Antalis, T.M.8
Sonza, S.9
Suhrbier, A.10
-
95
-
-
0027136633
-
Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular forms
-
DOI 10.1111/j.1432-1033.1993.tb18467.x
-
Mikus P, Urano T, Liljeström P, Ny T. Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular and extracellular forms. Eur J Biochem 1993 218 3 1071-1082 (Pubitemid 24010077)
-
(1993)
European Journal of Biochemistry
, vol.218
, Issue.3
, pp. 1071-1082
-
-
Mikus, P.1
Urano, T.2
Liljestrom, P.3
Ny, T.4
-
96
-
-
0037468520
-
The spontaneous polymerization of plasminogen activator inhibitor type-2 and Z-antitrypsin are due to different molecular aberrations
-
DOI 10.1016/S0014-5793(03)00057-7
-
Wilczynska M, Lobov S, Ny T. The spontaneous polymerization of plasminogen activator inhibitor type-2 and Z-antitrypsin are due to different molecular aberrations. FEBS Lett 2003 537 13 11-16 (Pubitemid 36246668)
-
(2003)
FEBS Letters
, vol.537
, Issue.1-3
, pp. 11-16
-
-
Wilczynska, M.1
Lobov, S.2
Ny, T.3
-
97
-
-
0029589824
-
What do dysfunctional serpins tell us about molecular mobility and disease?
-
DOI 10.1038/nsb0295-96
-
Stein P E., Carrell R W. What do dysfunctional serpins tell us about molecular mobility and disease? Nat Struct Biol 1995 2 2 96-113 (Pubitemid 26040647)
-
(1995)
Nature Structural Biology
, vol.2
, Issue.2
, pp. 96-113
-
-
Stein, P.E.1
Carrell, R.W.2
-
98
-
-
0033598346
-
Familial dementia caused by polymerization of mutant neuroserpin
-
DOI 10.1038/43897
-
Davis R L., Shrimpton A E., Holohan P D. et al. Familial dementia caused by polymerization of mutant neuroserpin. Nature 1999 401 6751 376-379 (Pubitemid 29454960)
-
(1999)
Nature
, vol.401
, Issue.6751
, pp. 376-379
-
-
Davis, R.L.1
Shrimpton, A.E.2
Holohan, P.D.3
Bradshaw, C.4
Feiglin, D.5
Collins, G.H.6
Sonderegger, P.7
Kinter, J.8
Becker, L.M.9
Lacbawan, F.10
Krasnewich, D.11
Muenke, M.12
Lawrence, D.A.13
Yerby, M.S.14
Shaw, C.-M.15
Gooptu, B.16
Elliott, P.R.17
Finch, J.T.18
Carrell, R.W.19
Lomas, D.A.20
more..
-
99
-
-
55249112306
-
Structural biology: Serpins' mystery solved
-
Whisstock J C., Bottomley S P. Structural biology: Serpins' mystery solved. Nature 2008 455 7217 1189-1190
-
(2008)
Nature
, vol.455
, Issue.7217
, pp. 1189-1190
-
-
Whisstock, J.C.1
Bottomley, S.P.2
-
100
-
-
59449110956
-
Gastrin activates paracrine networks leading to induction of PAI-2 via MAZ and ASC-1
-
Almeida-Vega S, Catlow K, Kenny S, Dimaline R, Varro A. Gastrin activates paracrine networks leading to induction of PAI-2 via MAZ and ASC-1. Am J Physiol Gastrointest Liver Physiol 2009 296 2 G414-G423
-
(2009)
Am J Physiol Gastrointest Liver Physiol
, vol.296
, Issue.2
-
-
Almeida-Vega, S.1
Catlow, K.2
Kenny, S.3
Dimaline, R.4
Varro, A.5
-
101
-
-
0025775491
-
Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoter
-
Cousin E, Medcalf R L., Bergonzelli G E., Kruithof E K. Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoter. Nucleic Acids Res 1991 19 14 3881-3886 (Pubitemid 21912756)
-
(1991)
Nucleic Acids Research
, vol.19
, Issue.14
, pp. 3881-3886
-
-
Cousin, E.1
Medcalf, R.L.2
Bergonzelli, G.E.3
Kruithof, E.K.O.4
-
102
-
-
0033179669
-
Plasminogen activator inhibitor type-2 (PAI-2) gene transcription requires a novel NF-κB-like transcriptional regulatory motif
-
DOI 10.1046/j.1432-1327.1999.00552.x
-
Mahony D, Kalionis B, Antalis T M. Plasminogen activator inhibitor type-2 (PAI-2) gene transcription requires a novel NF-kappaB-like transcriptional regulatory motif. Eur J Biochem 1999 263 3 765-772 (Pubitemid 29361949)
-
(1999)
European Journal of Biochemistry
, vol.263
, Issue.3
, pp. 765-772
-
-
Mahony, D.1
Kalionis, B.2
Antalis, T.M.3
-
103
-
-
0028299534
-
Localization and characterization of a retinoic acid response-like element in the plasminogen activator inhibitor-2 gene promoter
-
Schuster W A., Medcalf R L., Kruithof E KO. Localization and characterisation of a retinoic acid response-like element in the plasminogen activator inhibitor-2 gene promoter. Fibrinolysis 1994 8 113-119 (Pubitemid 24095970)
-
(1994)
Fibrinolysis
, vol.8
, Issue.2
, pp. 113-119
-
-
Schuster, W.A.1
Medcalf, R.L.2
Kruithof, E.K.O.3
-
104
-
-
0027435277
-
Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines
-
DOI 10.1210/en.133.4.1724
-
Schuster W A., Medcalf R L., Kruithof E K. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines. Endocrinology 1993 133 4 1724-1730 (Pubitemid 23295201)
-
(1993)
Endocrinology
, vol.133
, Issue.4
, pp. 1724-1730
-
-
Schuster, W.A.1
Medcalf, R.L.2
Kruithof, E.K.O.3
-
105
-
-
0025934316
-
Targets for dioxin: Genes for plasminogen activator inhibitor-2 and interleukin-1β
-
Sutter T R., Guzman K, Dold K M., Greenlee W F. Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1 beta. Science 1991 254 5030 415-418 (Pubitemid 21917355)
-
(1991)
Science
, vol.254
, Issue.5030
, pp. 415-418
-
-
Sutter, T.R.1
Guzman, K.2
Dold, K.M.3
Greenlee, W.F.4
-
106
-
-
0029803572
-
Regulation of the plasminogen activator inhibitor type-2 gene in monocytes: Localization of an upstream transcriptional silencer
-
Antalis T M., Costelloe E, Muddiman J, Ogbourne S, Donnan K. Regulation of the plasminogen activator inhibitor type-2 gene in monocytes: localization of an upstream transcriptional silencer. Blood 1996 88 10 3686-3697 (Pubitemid 26383090)
-
(1996)
Blood
, vol.88
, Issue.10
, pp. 3686-3697
-
-
Antalis, T.M.1
Costelloe, E.2
Muddiman, J.3
Ogbourne, S.4
Donnan, K.5
-
107
-
-
0029833158
-
Molecular mechanisms governing tumor-necrosis-factor-mediated regulation of plasminogen-activator inhibitor type-2 gene expression
-
Dear A E., Shen Y, Rüegg M, Medcalf R L. Molecular mechanisms governing tumor-necrosis-factor-mediated regulation of plasminogen-activator inhibitor type-2 gene expression. Eur J Biochem 1996 241 1 93-100 (Pubitemid 26342976)
-
(1996)
European Journal of Biochemistry
, vol.241
, Issue.1
, pp. 93-100
-
-
Dear, A.E.1
Shen, Y.2
Ruegg, M.3
Medcalf, R.L.4
-
108
-
-
0035477917
-
Characterisation of PAUSE-1, a powerful silencer in the human plasminogen activator inhibitor type 2 gene promoter
-
Ogbourne S M., Antalis T M. Characterisation of PAUSE-1, a powerful silencer in the human plasminogen activator inhibitor type 2 gene promoter. Nucleic Acids Res 2001 29 19 3919-3927 (Pubitemid 32962681)
-
(2001)
Nucleic Acids Research
, vol.29
, Issue.19
, pp. 3919-3927
-
-
Ogbourne, S.M.1
Antalis, T.M.2
-
109
-
-
0033118843
-
An AU-rich sequence in the 3'-UTR of plasminogen activator inhibitor type 2 (PAI-2) mRNA promotes PAI-2 mRNA decay and provides a binding site for nuclear HuR
-
DOI 10.1093/nar/27.7.1664
-
Maurer F, Tierney M, Medcalf R L. An AU-rich sequence in the 3-UTR of plasminogen activator inhibitor type 2 (PAI-2) mRNA promotes PAI-2 mRNA decay and provides a binding site for nuclear HuR. Nucleic Acids Res 1999 27 7 1664-1673 (Pubitemid 29209542)
-
(1999)
Nucleic Acids Research
, vol.27
, Issue.7
, pp. 1664-1673
-
-
Maurer, F.1
Tierney, M.2
Medcalf, R.L.3
-
110
-
-
0029979717
-
Plasminogen activator inhibitor type 2 gene induction by tumor necrosis factor and phorbol ester involves transcriptional and post-transcriptional events. Identification of a functional nonameric AU-rich motif in the 3'- untranslated region
-
DOI 10.1074/jbc.271.42.26074
-
Maurer F, Medcalf R L. Plasminogen activator inhibitor type 2 gene induction by tumor necrosis factor and phorbol ester involves transcriptional and post-transcriptional events. Identification of a functional nonameric AU-rich motif in the 3-untranslated region. J Biol Chem 1996 271 42 26074-26080 (Pubitemid 26347448)
-
(1996)
Journal of Biological Chemistry
, vol.271
, Issue.42
, pp. 26074-26080
-
-
Maurer, F.1
Medcalf, R.L.2
-
111
-
-
0037853206
-
Inherent instability of plasminogen activator inhibitor type 2 mRNA is regulated by tristetraprolin
-
DOI 10.1074/jbc.M213027200
-
Yu H, Stasinopoulos S, Leedman P, Medcalf R L. Inherent instability of plasminogen activator inhibitor type 2 mRNA is regulated by tristetraprolin. J Biol Chem 2003 278 16 13912-13918 (Pubitemid 36799932)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.16
, pp. 13912-13918
-
-
Yu, H.1
Stasinopoulos, S.2
Leedman, P.3
Medcalf, R.L.4
-
112
-
-
0035957987
-
Plasminogen activator inhibitor type 2 contains mRNA instability elements within exon 4 of the coding region. Sequence homology to coding region instability determinants in other mRNAs
-
Tierney M J., Medcalf R L. Plasminogen activator inhibitor type 2 contains mRNA instability elements within exon 4 of the coding region. Sequence homology to coding region instability determinants in other mRNAs. J Biol Chem 2001 276 17 13675-13684
-
(2001)
J Biol Chem
, vol.276
, Issue.17
, pp. 13675-13684
-
-
Tierney, M.J.1
Medcalf, R.L.2
-
113
-
-
0033582335
-
The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival
-
DOI 10.1073/pnas.96.2.686
-
Dougherty K M., Pearson J M., Yang A Y., Westrick R J., Baker M S., Ginsburg D. The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival. Proc Natl Acad Sci U S A 1999 96 2 686-691 (Pubitemid 29061269)
-
(1999)
Proceedings of the National Academy of Sciences of the United States of America
, vol.96
, Issue.2
, pp. 686-691
-
-
Dougherty, K.M.1
Pearson, J.M.2
Yang, A.Y.3
Westrick, R.J.4
Baker, M.S.5
Ginsburg, D.6
-
114
-
-
0034528914
-
Early embryonic expression of murine coagulation system components
-
Ong K, Horsfall W, Conway E M., Schuh A C. Early embryonic expression of murine coagulation system components. Thromb Haemost 2000 84 6 1023-1030 (Pubitemid 32014039)
-
(2000)
Thrombosis and Haemostasis
, vol.84
, Issue.6
, pp. 1023-1030
-
-
Ong, K.1
Horsfall, W.2
Conway, E.M.3
Schuh, A.C.4
-
115
-
-
0000995740
-
Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor
-
Antalis T M., Clark M A., Barnes T et al. Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor. Proc Natl Acad Sci U S A 1988 85 4 985-989 (Pubitemid 18073947)
-
(1988)
Proceedings of the National Academy of Sciences of the United States of America
, vol.85
, Issue.4
, pp. 985-989
-
-
Antalis, T.M.1
Clark, M.A.2
Barnes, T.3
Lehrbach, P.R.4
Devine, P.L.5
Schevzov, G.6
Goss, N.H.7
Stephens, R.W.8
Tolstoshev, P.9
-
116
-
-
0025269314
-
The human gene for plasminogen activator inhibitor 2 (PAI2) exhibits an EcoRI RFLP
-
van den Berg E A., le Clercq E, Kooistra T, Frants R R., Bakker E. The human gene for plasminogen activator inhibitor 2 (PAI2) exhibits an EcoRI RFLP. Nucleic Acids Res 1990 18 9 2837 (Pubitemid 20150665)
-
(1990)
Nucleic Acids Research
, vol.18
, Issue.9
, pp. 2837
-
-
Van Den Berg, E.A.1
Le Clercq, E.2
Kooistra, T.3
Frants, R.R.4
Bakker, E.5
-
117
-
-
64549131747
-
A functional Ser(413)/Ser(413) PAI-2 polymorphism is associated with susceptibility and damage index score in systemic lupus erythematosus
-
Palafox-Sánchez C A., Vázquez-Del Mercado M, Orozco-Barocio G et al. A functional Ser(413)/Ser(413) PAI-2 polymorphism is associated with susceptibility and damage index score in systemic lupus erythematosus. Clin Appl Thromb Hemost 2009 15 2 233-238
-
(2009)
Clin Appl Thromb Hemost
, vol.15
, Issue.2
, pp. 233-238
-
-
Palafox-Sánchez, C.A.1
Vázquez-Del Mercado, M.2
Orozco-Barocio, G.3
-
118
-
-
34547493556
-
Genotype Ser413/Ser of PAI-2 polymorphism Ser413/Cys is associated with anti-phospholipid syndrome and systemic lupus erythematosus in a familial case: Comparison with healthy controls
-
Vázquez-Del Mercado M, García-Cobian T A., Muñoz Valle J F. et al. Genotype Ser413/Ser of PAI-2 polymorphism Ser413/Cys is associated with anti-phospholipid syndrome and systemic lupus erythematosus in a familial case: comparison with healthy controls. Scand J Rheumatol 2007 36 3 206-210
-
(2007)
Scand J Rheumatol
, vol.36
, Issue.3
, pp. 206-210
-
-
Vázquez-Del Mercado, M.1
García-Cobian, T.A.2
Muñoz Valle, J.F.3
-
119
-
-
0242523108
-
PCR-RFLP Detection of PAI-2 Variants in Myocardial Infarction
-
Buyru N, Altinisik J, Gurel C B., Ulutin T. PCR-RFLP detection of PAI-2 variants in myocardial infarction. Clin Appl Thromb Hemost 2003 9 4 333-336 (Pubitemid 37414124)
-
(2003)
Clinical and Applied Thrombosis/Hemostasis
, vol.9
, Issue.4
, pp. 333-336
-
-
Buyru, N.1
Altinisik, J.2
Gurel, C.B.3
Ulutin, T.4
-
120
-
-
2342591299
-
Large scale association analysis for identification of genes underlying premature coronary heart disease: Cumulative perspective from analysis of 111 candidate genes
-
McCarthy J J., Parker A, Salem R et al, GeneQuest Investigators. Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes. J Med Genet 2004 41 5 334-341 (Pubitemid 38608515)
-
(2004)
Journal of Medical Genetics
, vol.41
, Issue.5
, pp. 334-341
-
-
McCarthy, J.J.1
Parker, A.2
Salem, R.3
Moliterno, D.J.4
Wang, Q.5
Plow, E.F.6
Rao, S.7
Shen, G.8
Rogers, W.J.9
Newby, L.K.10
Cannata, R.11
Glatt, K.12
Topol, E.J.13
-
121
-
-
0030960262
-
PCR-RFLP detection of PAI-2 gene variants: Prevalence in ethnic groups and disease relationship in patients undergoing coronary angiography
-
Foy C A., Grant P J. PCR-RFLP detection of PAI-2 gene variants: prevalence in ethnic groups and disease relationship in patients undergoing coronary angiography. Thromb Haemost 1997 77 5 955-958 (Pubitemid 27239121)
-
(1997)
Thrombosis and Haemostasis
, vol.77
, Issue.5
, pp. 955-958
-
-
Foy, C.A.1
Grant, P.J.2
-
122
-
-
27644528117
-
Nucleotide variations in genes encoding plasminogen activator inhibitor-2 and serine proteinase inhibitor B10 associated with prostate cancer
-
DOI 10.1007/s10038-005-0285-1
-
Shioji G, Ezura Y, Nakajima T et al. Nucleotide variations in genes encoding plasminogen activator inhibitor-2 and serine proteinase inhibitor B10 associated with prostate cancer. J Hum Genet 2005 50 10 507-515 (Pubitemid 41571165)
-
(2005)
Journal of Human Genetics
, vol.50
, Issue.10
, pp. 507-515
-
-
Shioji, G.1
Ezura, Y.2
Nakajima, T.3
Ohgaki, K.4
Fujiwara, H.5
Kubota, Y.6
Ichikawa, T.7
Inoue, K.8
Shuin, T.9
Habuchi, T.10
Ogawa, O.11
Nishimura, T.12
Emi, M.13
-
123
-
-
33846661421
-
Genetic polymorphisms and spontaneous preterm birth
-
DOI 10.1097/01.AOG.0000252712.62241.1a, PII 0000625020070200000023
-
Gibson C S., MacLennan A H., Dekker G A. et al. Genetic polymorphisms and spontaneous preterm birth. Obstet Gynecol 2007 109 2 Pt 1 384-391 (Pubitemid 46197432)
-
(2007)
Obstetrics and Gynecology
, vol.109
, Issue.2 PART 1
, pp. 384-391
-
-
Gibson, C.S.1
MacLennan, A.H.2
Dekker, G.A.3
Goldwater, P.N.4
Dambrosia, J.M.5
Munroe, D.J.6
Tsang, S.7
Stewart, C.8
Nelson, K.B.9
-
124
-
-
67449156434
-
Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis
-
GELCAPS Consortium 2
-
Di Bernardo M C., Matakidou A, Eisen T, Houlston R S., GELCAPS Consortium. Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis. Lung Cancer 2009 65 2 237-241
-
(2009)
Lung Cancer
, vol.65
, pp. 237-241
-
-
Di Bernardo, M.C.1
Matakidou, A.2
Eisen, T.3
Houlston, R.S.4
-
125
-
-
0025288990
-
Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors
-
Ellis V, Wun T C., Behrendt N, Rønne E, Danø K. Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors. J Biol Chem 1990 265 17 9904-9908
-
(1990)
J Biol Chem
, vol.265
, Issue.17
, pp. 9904-9908
-
-
Ellis, V.1
Wun, T.C.2
Behrendt, N.3
Rønne, E.4
Danø, K.5
-
126
-
-
0023680099
-
Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes
-
Medcalf R L., Kruithof E K., Schleuning W D. Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes. J Exp Med 1988 168 2 751-759
-
(1988)
J Exp Med
, vol.168
, Issue.2
, pp. 751-759
-
-
Medcalf, R.L.1
Kruithof, E.K.2
Schleuning, W.D.3
-
127
-
-
0025103776
-
Plasminogen activator inhibitor type-2 is a major protein induced in human fibroblasts and SK-MEL-109 melanoma cells by tumor necrosis factor
-
Pytel B A., Peppel K, Baglioni C. Plasminogen activator inhibitor type-2 is a major protein induced in human fibroblasts and SK-MEL-109 melanoma cells by tumor necrosis factor. J Cell Physiol 1990 144 3 416-422
-
(1990)
J Cell Physiol
, vol.144
, Issue.3
, pp. 416-422
-
-
Pytel, B.A.1
Peppel, K.2
Baglioni, C.3
-
128
-
-
0026625179
-
Urokinase expression in mononuclear phagocytes: Cytokine-specific modulation by interferon-gamma and tumor necrosis factor-alpha
-
Gyetko M R., Shollenberger S B., Sitrin R G. Urokinase expression in mononuclear phagocytes: cytokine-specific modulation by interferon-gamma and tumor necrosis factor-alpha. J Leukoc Biol 1992 51 3 256-263
-
(1992)
J Leukoc Biol
, vol.51
, Issue.3
, pp. 256-263
-
-
Gyetko, M.R.1
Shollenberger, S.B.2
Sitrin, R.G.3
-
129
-
-
8744294747
-
Analysis of proteome and transcriptome of tumor necrosis factor alpha stimulated vascular smooth muscle cells with or without alpha lipoic acid
-
Jang W G., Kim H S., Park K G. et al. Analysis of proteome and transcriptome of tumor necrosis factor alpha stimulated vascular smooth muscle cells with or without alpha lipoic acid. Proteomics 2004 4 11 3383-3393
-
(2004)
Proteomics
, vol.4
, Issue.11
, pp. 3383-3393
-
-
Jang, W.G.1
Kim, H.S.2
Park, K.G.3
-
130
-
-
0031839409
-
Regulation of the level and glycosylation state of plasminogen activator inhibitor type 2 during human keratinocyte differentiation
-
DOI 10.1046/j.1432-0436.1998.6320093.x
-
Wang Y, Jensen P J. Regulation of the level and glycosylation state of plasminogen activator inhibitor type 2 during human keratinocyte differentiation. Differentiation 1998 63 2 93-99 (Pubitemid 28301936)
-
(1998)
Differentiation
, vol.63
, Issue.2
, pp. 93-99
-
-
Wang, Y.1
Jensen, P.J.2
-
131
-
-
0141960414
-
Is interferon γ one key of metastatic potential increase in human bladder carcinoma?
-
Champelovier P, Simon A, Garrel C, Levacher G, Praloran V, Seigneurin D. Is interferon gamma one key of metastatic potential increase in human bladder carcinoma? Clin Cancer Res 2003 9 12 4562-4569 (Pubitemid 37248416)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.12
, pp. 4562-4569
-
-
Champelovier, P.1
Simon, A.2
Garrel, C.3
Levacher, G.4
Praloran, V.5
Seigneurin, D.6
-
132
-
-
0026557463
-
Regulation of proteolytic activity in human bone marrow stromal cells by basic fibroblast growth factor, interleukin-1, and transforming growth factor beta
-
Hannocks M J., Oliver L, Gabrilove J L., Wilson E L. Regulation of proteolytic activity in human bone marrow stromal cells by basic fibroblast growth factor, interleukin-1, and transforming growth factor beta. Blood 1992 79 5 1178-1184
-
(1992)
Blood
, vol.79
, Issue.5
, pp. 1178-1184
-
-
Hannocks, M.J.1
Oliver, L.2
Gabrilove, J.L.3
Wilson, E.L.4
-
134
-
-
0027454577
-
Contrasting effects of transforming growth factor-β and IL-1 on the regulation of plasminogen activator inhibitors in human synovial fibroblasts
-
Hamilton J A., Wojta J, Gallichio M, McGrath K, Filonzi E L. Contrasting effects of transforming growth factor-beta and IL-1 on the regulation of plasminogen activator inhibitors in human synovial fibroblasts. J Immunol 1993 151 10 5154-5161 (Pubitemid 23332325)
-
(1993)
Journal of Immunology
, vol.151
, Issue.10
, pp. 5154-5161
-
-
Hamilton, J.A.1
Wojta, J.2
Gallichio, M.3
McGrath, K.4
Filonzi, E.L.5
-
135
-
-
35649028488
-
Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids
-
DOI 10.1073/pnas.0707413104
-
Woodruff P G., Boushey H A., Dolganov G M. et al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci U S A 2007 104 40 15858-15863 (Pubitemid 350035389)
-
(2007)
Proceedings of the National Academy of Sciences of the United States of America
, vol.104
, Issue.40
, pp. 15858-15863
-
-
Woodruff, P.G.1
Boushey, H.A.2
Dolganov, G.M.3
Barker, C.S.4
Yee, H.Y.5
Donnelly, S.6
Ellwanger, A.7
Sidhu, S.S.8
Dao-Pick, T.P.9
Pantoja, C.10
Erle, D.J.11
Yamamoto, K.R.12
Fahy, J.V.13
-
136
-
-
0025527018
-
Modulation of tPA, PAI-1 and PAI-2 antigen and mRNA levels by EGF in the A431 cell line
-
George F, Pourreau-Schneider N, Arnoux D et al. Modulation of tPA, PAI-1 and PAI-2 antigen and mRNA levels by EGF in the A431 cell line. Blood Coagul Fibrinolysis 1990 1 6 689-693
-
(1990)
Blood Coagul Fibrinolysis
, vol.1
, Issue.6
, pp. 689-693
-
-
George, F.1
Pourreau-Schneider, N.2
Arnoux, D.3
-
137
-
-
0027536449
-
Regulation of plasminogen activator inhibitor-1 and -2 messenger ribonucleic acid levels in human cumulus and granulosa-luteal cells
-
DOI 10.1210/jc.76.2.518
-
Piquette G N., Crabtree M E., el-Danasouri I, Milki A, Polan M L. Regulation of plasminogen activator inhibitor-1 and -2 messenger ribonucleic acid levels in human cumulus and granulosa-luteal cells. J Clin Endocrinol Metab 1993 76 2 518-523 (Pubitemid 23073085)
-
(1993)
Journal of Clinical Endocrinology and Metabolism
, vol.76
, Issue.2
, pp. 518-523
-
-
Piquette, G.N.1
Crabtree, M.E.2
El-Danasouri, I.3
Milki, A.4
Polan, M.L.5
-
138
-
-
0023840321
-
Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2
-
Medcalf R L., Van den Berg E, Schleuning W D. Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2. J Cell Biol 1988 106 3 971-978 (Pubitemid 18089997)
-
(1988)
Journal of Cell Biology
, vol.106
, Issue.3
, pp. 971-978
-
-
Medcalf, R.L.1
Van Den Berg, E.2
Schleuning, W.-D.3
-
139
-
-
0026649392
-
Regulation of plasminogen activator inhibitor mRNA levels in lipopolysaccharide-stimulated human monocytes. Correlation with production of the protein
-
Schwartz B S., Bradshaw J D. Regulation of plasminogen activator inhibitor mRNA levels in lipopolysaccharide-stimulated human monocytes. Correlation with production of the protein. J Biol Chem 1992 267 10 7089-7094
-
(1992)
J Biol Chem
, vol.267
, Issue.10
, pp. 7089-7094
-
-
Schwartz, B.S.1
Bradshaw, J.D.2
-
140
-
-
0033040334
-
Regulation of the plasminogen activator inhibitor-2 (PAI-2) gene in murine macrophages. Demonstration of a novel pattern of responsiveness to bacterial endotoxin
-
Costelloe E O., Stacey K J., Antalis T M., Hume D A. Regulation of the plasminogen activator inhibitor-2 (PAI-2) gene in murine macrophages. Demonstration of a novel pattern of responsiveness to bacterial endotoxin. J Leukoc Biol 1999 66 1 172-182 (Pubitemid 29321386)
-
(1999)
Journal of Leukocyte Biology
, vol.66
, Issue.1
, pp. 172-182
-
-
Costelloe, E.O.1
Stacey, K.J.2
Antalis, T.M.3
Hume, D.A.4
-
141
-
-
0034307661
-
Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE
-
Suzuki T, Hashimoto S, Toyoda N et al. Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE. Blood 2000 96 7 2584-2591
-
(2000)
Blood
, vol.96
, Issue.7
, pp. 2584-2591
-
-
Suzuki, T.1
Hashimoto, S.2
Toyoda, N.3
-
142
-
-
5044252342
-
Modulating effect of serum on the stimulation of plasminogen activator inhibitor 2 production in human gingival fibroblasts by lipopolysaccharide and interleukin-1beta
-
Xiao Y, Bartold P M. Modulating effect of serum on the stimulation of plasminogen activator inhibitor 2 production in human gingival fibroblasts by lipopolysaccharide and interleukin-1beta. J Int Acad Periodontol 2004 6 3 81-88
-
(2004)
J Int Acad Periodontol
, vol.6
, Issue.3
, pp. 81-88
-
-
Xiao, Y.1
Bartold, P.M.2
-
143
-
-
0028357238
-
Different regulation of plasminogen activator inhibitor 2 gene expression by phorbol ester and cAMP in human myeloid leukemia cell line PL-21
-
Niiya K, Taniguchi T, Shinbo M et al. Different regulation of plasminogen activator inhibitor 2 gene expression by phorbol ester and cAMP in human myeloid leukemia cell line PL-21. Thromb Haemost 1994 72 1 92-97 (Pubitemid 24202302)
-
(1994)
Thrombosis and Haemostasis
, vol.72
, Issue.1
, pp. 92-97
-
-
Niiya, K.1
Taniguchi, T.2
Shinbo, M.3
Ishikawa, T.-I.4
Tazawa, S.5
Hayakawa, Y.6
Sakuragawa, N.7
-
144
-
-
0036456322
-
Identification of calcium-induced genes in HaCaT keratinocytes by polymerase chain reaction-based subtractive hybridization
-
Seo E Y., Piao Y J., Kim J S., Suhr K B., Park J K., Lee J H. Identification of calcium-induced genes in HaCaT keratinocytes by polymerase chain reaction-based subtractive hybridization. Arch Dermatol Res 2002 294 9 411-418
-
(2002)
Arch Dermatol Res
, vol.294
, Issue.9
, pp. 411-418
-
-
Seo, E.Y.1
Piao, Y.J.2
Kim, J.S.3
Suhr, K.B.4
Park, J.K.5
Lee, J.H.6
-
145
-
-
27544477421
-
Molecular mechanisms of the 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced inverted U-shaped dose responsiveness in anchorage independent growth and cell proliferation of human breast epithelial cells with stem cell characteristics
-
DOI 10.1016/j.mrfmmm.2005.03.026, PII S0027510705002599
-
Ahn N S., Hu H, Park J S. et al. Molecular mechanisms of the 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced inverted U-shaped dose responsiveness in anchorage independent growth and cell proliferation of human breast epithelial cells with stem cell characteristics. Mutat Res 2005 579 12 189-199 (Pubitemid 41540143)
-
(2005)
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
, vol.579
, Issue.1-2
, pp. 189-199
-
-
Ahn, N.-S.1
Hu, H.2
Park, J.-S.3
Park, J.-S.4
Kim, J.-S.5
An, S.6
Kong, G.7
Aruoma, O.I.8
Lee, Y.-S.9
Kang, K.-S.10
-
146
-
-
0037103926
-
Plasminogen mRNA induction in the mouse brain after kainate excitation: Codistribution with plasminogen activator inhibitor-2 (PAI-2) mRNA
-
Sharon R, Abramovitz R, Miskin R. Plasminogen mRNA induction in the mouse brain after kainate excitation: codistribution with plasminogen activator inhibitor-2 (PAI-2) mRNA. Brain Res Mol Brain Res 2002 104 2 170-175
-
(2002)
Brain Res Mol Brain Res
, vol.104
, Issue.2
, pp. 170-175
-
-
Sharon, R.1
Abramovitz, R.2
Miskin, R.3
-
147
-
-
0026735987
-
Cell- and gene-specific interactions between signal transduction pathways revealed by okadaic acid. Studies on the plasminogen activating system
-
Medcalf R L. Cell- and gene-specific interactions between signal transduction pathways revealed by okadaic acid. Studies on the plasminogen activating system. J Biol Chem 1992 267 17 12220-12226
-
(1992)
J Biol Chem
, vol.267
, Issue.17
, pp. 12220-12226
-
-
Medcalf, R.L.1
-
148
-
-
0034697819
-
The novel anti-tumour agent oxamflatin differentially regulates urokinase and plasminogen activator inhibitor type 2 expression and inhibits urokinase-mediated proteolytic activity
-
DOI 10.1016/S0167-4781(00)00041-5, PII S0167478100000415
-
Dear A E., Medcalf R L. The novel anti-tumour agent oxamflatin differentially regulates urokinase and plasminogen activator inhibitor type 2 expression and inhibits urokinase-mediated proteolytic activity. Biochim Biophys Acta 2000 1492 1 15-22 (Pubitemid 30349176)
-
(2000)
Biochimica et Biophysica Acta - Gene Structure and Expression
, vol.1492
, Issue.1
, pp. 15-22
-
-
Dear, A.E.1
Medcalf, R.L.2
-
149
-
-
0023637406
-
Plasminogen activator inhibitor 2: Regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells
-
Schleuning W D., Medcalf R L., Hession C, Rothenbühler R, Shaw A, Kruithof E K. Plasminogen activator inhibitor 2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells. Mol Cell Biol 1987 7 12 4564-4567 (Pubitemid 17166406)
-
(1987)
Molecular and Cellular Biology
, vol.7
, Issue.12
, pp. 4564-4567
-
-
Schleuning, W.-D.1
Medcalf, R.L.2
Hession, C.3
Rothenbuhler, R.4
Shaw, A.5
Kruithof, E.K.O.6
-
150
-
-
0028966472
-
Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells
-
Feener E P., Northrup J M., Aiello L P., King G L. Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest 1995 95 3 1353-1362
-
(1995)
J Clin Invest
, vol.95
, Issue.3
, pp. 1353-1362
-
-
Feener, E.P.1
Northrup, J.M.2
Aiello, L.P.3
King, G.L.4
-
151
-
-
0026074491
-
FDP D-dimer induces the secretion of interleukin-1, urokinase-type plasminogen activator, and plasminogen activator inhibitor-2 in a human promonocytic leukemia cell line
-
Hamaguchi M, Morishita Y, Takahashi I, Ogura M, Takamatsu J, Saito H. FDP D-dimer induces the secretion of interleukin-1, urokinase-type plasminogen activator, and plasminogen activator inhibitor-2 in a human promonocytic leukemia cell line. Blood 1991 77 1 94-100
-
(1991)
Blood
, vol.77
, Issue.1
, pp. 94-100
-
-
Hamaguchi, M.1
Morishita, Y.2
Takahashi, I.3
Ogura, M.4
Takamatsu, J.5
Saito, H.6
-
152
-
-
0034010134
-
Binding of factor VIIa to tissue factor on keratinocytes induces gene expression
-
DOI 10.1074/jbc.275.9.6580
-
Camerer E, Gjernes E, Wiiger M, Pringle S, Prydz H. Binding of factor VIIa to tissue factor on keratinocytes induces gene expression. J Biol Chem 2000 275 9 6580-6585 (Pubitemid 30129959)
-
(2000)
Journal of Biological Chemistry
, vol.275
, Issue.9
, pp. 6580-6585
-
-
Camerer, E.1
Gjernes, E.2
Wiiger, M.3
Pringle, S.4
Prydz, H.5
-
153
-
-
0028818516
-
Thrombin modulates synthesis of plasminogen activator inhibitor type 2 by human peripheral blood monocytes
-
Ritchie H, Jamieson A, Booth N A. Thrombin modulates synthesis of plasminogen activator inhibitor type 2 by human peripheral blood monocytes. Blood 1995 86 9 3428-3435
-
(1995)
Blood
, vol.86
, Issue.9
, pp. 3428-3435
-
-
Ritchie, H.1
Jamieson, A.2
Booth, N.A.3
-
154
-
-
0028143966
-
Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy
-
Lundgren C H., Sawa H, Sobel B E., Fujii S. Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy. Circulation 1994 90 4 1927-1934 (Pubitemid 24320944)
-
(1994)
Circulation
, vol.90
, Issue.4
, pp. 1927-1934
-
-
Lundgren, C.H.1
Sawa, H.2
Sobel, B.E.3
Fujii, S.4
-
155
-
-
0035865605
-
Lipoprotein (a) up-regulates the expression of the plasminogen activator inhibitor 2 in human blood monocytes
-
DOI 10.1182/blood.V97.4.981
-
Buechler C, Ullrich H, Ritter M et al. Lipoprotein (a) up-regulates the expression of the plasminogen activator inhibitor 2 in human blood monocytes. Blood 2001 97 4 981-986 (Pubitemid 32154283)
-
(2001)
Blood
, vol.97
, Issue.4
, pp. 981-986
-
-
Buechler, C.1
Ullrich, H.2
Ritter, M.3
Porsch-Oezcueruemez, M.4
Lackner, K.J.5
Barlage, S.6
Friedrich, S.O.7
Kostner, G.M.8
Schmitz, G.9
-
156
-
-
0035008953
-
Retinoic acid upregulates the plasminogen activator system in human epidermal keratinocytes
-
DOI 10.1046/j.1523-1747.2001.01310.x
-
Braungart E, Magdolen V, Degitz K. Retinoic acid upregulates the plasminogen activator system in human epidermal keratinocytes. J Invest Dermatol 2001 116 5 778-784 (Pubitemid 32467660)
-
(2001)
Journal of Investigative Dermatology
, vol.116
, Issue.5
, pp. 778-784
-
-
Braungart, E.1
Magdolen, V.2
Degitz, K.3
-
157
-
-
0032726657
-
Retinoic acid stimulates plasminogen activator inhibitor 2 production by blood mononuclear cells and inhibits urokinase-induced extracellular proteolysis
-
DOI 10.1046/j.1365-2141.1999.01698.x
-
Montemurro P, Barbuti G, Conese M et al. Retinoic acid stimulates plasminogen activator inhibitor 2 production by blood mononuclear cells and inhibits urokinase-induced extracellular proteolysis. Br J Haematol 1999 107 2 294-299 (Pubitemid 29530213)
-
(1999)
British Journal of Haematology
, vol.107
, Issue.2
, pp. 294-299
-
-
Montemurro, P.1
Barbuti, G.2
Conese, M.3
Gabriele, S.4
Petio, M.5
Colucci, M.6
Semeraro, N.7
-
158
-
-
0028670123
-
Effect of lipoproteins on tissue factor activity and PAI-II antigen in human monocytes and macrophages
-
DOI 10.1016/0167-5273(94)90322-0
-
Wada H, Kaneko T, Wakita Y et al. Effect of lipoproteins on tissue factor activity and PAI-II antigen in human monocytes and macrophages. Int J Cardiol 1994 47 1, Suppl S21-S25 (Pubitemid 124013269)
-
(1994)
International Journal of Cardiology
, vol.47
, Issue.1 SUPPL. 1
-
-
Wada, H.1
Kaneko, T.2
Wakita, Y.3
Minamikawa, K.4
Nagaya, S.5
Tamaki, S.6
Deguchi, K.7
Shirakawa, S.8
-
159
-
-
0035900743
-
Crystal structure of the complex of plasminogen activator inhibitor 2 with a peptide mimicking the reactive center loop
-
Jankova L, Harrop S J., Saunders D N. et al. Crystal structure of the complex of plasminogen activator inhibitor 2 with a peptide mimicking the reactive center loop. J Biol Chem 2001 276 46 43374-43382
-
(2001)
J Biol Chem
, vol.276
, Issue.46
, pp. 43374-43382
-
-
Jankova, L.1
Harrop, S.J.2
Saunders, D.N.3
|